
Please try another search
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet. It is also involved in the provision of biological peptides, industrial hemp, and medical service business; and food and beverages, and cosmetics under the Hanhui, Xiao Lan, Ruyin Fangxing, and Ma Yuansu brands. The company was founded in 1980 and is based in Beijing, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Bin Wu | 65 | 2021 | Independent Director |
Sinian Chou | 43 | 2021 | Non-Independent Director |
Ping Liu | 45 | 2023 | Supervisor |
Feng Han | 55 | 2022 | Director |
Xin An Wang | 61 | 2021 | Independent Director |
Weihong Sun | 62 | 2021 | Independent Director |
Hailin Yan | 48 | 2021 | Non-Independent Director |
Zheming Wei | 43 | 2016 | Chairman & Acting Secretary |
Wei Liu | 55 | 2016 | Co-Chairman & GM |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review